VeriChip Corp. (CHIP) & RECEPTORS LLC Announce Successful Phase 1 Completion of Implantable Glucose Sensing RFID Microchip
VeriChip Corporation and its partner in product development, RECEPTORS LLC, said today that they have made an important advancement in the design of a radio frequency identification (RFID) microchip that can be implanted in living organisms, or “in vivo”, to detect and monitor glucose levels. One important potential application of this type of RFID device is to help diabetics monitor their glucose levels. This application could eliminate the need for diabetics to monitor their blood sugar levels by pricking their skin and drawing blood several times per day. Asked for comment on this ground-breaking Phase 1 milestone, Scott R. Silverman,…